EZH2 and acute monocytic leukemia: EZH2 is overexpressed in pediatric acute monocytic leukemia and the GSK126, UNC1999 and EPZ-5687 inhibitors suppresses the EZH2 activity on H3K27 leading to a reduction of proliferation and increased apoptosis.